Fixed drug eruption to cetirizine with positive lesional patch tests to the three piperazine derivatives

International Journal of Dermatology

Volumn 46, Issue 7, 2007, Pages 760-762

  Cravo, Mariana ^a   Gonçalo, Margarida ^a   Figueiredo, Américo ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; HYDROXYZINE; LEVOCETIRIZINE; METHYLPREDNISOLONE; NIMESULIDE; PETROLATUM; PIPERAZINE DERIVATIVE; PIROXICAM; WATER;

ADULT; ALLERGIC RHINITIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG CROSS REACTIVITY; DRUG SCREENING; DRUG SYNTHESIS; FEMALE; FIXED DRUG ERUPTION; HUMAN; PATCH TEST; PILL; POWDER;

CETIRIZINE; CROSS REACTIONS; DRUG ERUPTIONS; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; MIDDLE AGED; PATCH TESTS; PIPERAZINES; RHINITIS, ALLERGIC, SEASONAL; SKIN;

EID: 34447253523     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03131.x     Document Type: Article

References (13)

1. Assouere MN, Mazereeuw-Hautier J, Bonafe JL. Cutaneous drug eruption with two antihistaminic drugs of the same chemical family: Cetirizine and hydroxyzine. Ann Dermatol Venereol 2002; 129: 1295-1298.
2. Barbaud A, Gonçalo M, Bruynzeel D, et al. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001; 45: 321-328.
3. Mahajan VK, Sharma NL, Sharma VC. Fixed drug eruption: A novel side-effect of levocetirizine. Int J Dermatol 2005; 44: 796-798.
4. Pionetti CH, Kien MC, Alonso A. Fixed drug eruption due to loratadine. Allergol Immunopathol (Madr) 2003; 31: 291-293.
5. Kauppinen K, Stubb S. Fixed eruptions: Causative drugs and challenge tests. Br J Dermatol 1985; 112: 575-578.
6. Oliveira HS, Gonçalo M, Reis JP, et al. Fixed drug eruption to piroxicam. Positive patch tests with cross-sensivity to tenoxicam. J Dermatol Treat 1999; 10: 209-212.
7. Gonçalo M, Oliveira HS, Fernandes B, et al. Topical provocation in fixed drug eruption from nonsteroidal anti-inflammatory drugs. Exogenous Dermatol 2002; 1: 81-86.
8. Robalo Cordeiro M, Gonçalo M, Fernandes B, et al. Positive lesional patch tests in fixed drug eruptions from nimesulide. Contact Dermatitis 2000; 43: 307.
9. Ruiz-Genao DP, Hernandez-Nunez A, Sanchez J, et al. Fixed drug eruption due to loratadine. Br J Dermatol 2002; 146: 528-529.
10. Kranke B, Kern T. Multilocalized fixed drug eruption to the antihistamine cetirizine. J Allergy Clin Immunol 2000; 106: 988.
11. Inamadar AC, Palit A, Athanikar SB, et al. Multiple fixed drug eruptions due to cetirizine. Br J Dermatol 2002; 146: 528-529.
12. Crowson A, Magro C. Recent advances in the pathology of cutaneous drug eruptions. Dermatol Clin 1999; 17: 537.
13. Barbaud A, Reichert-Penetrat S, Trechot P, et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998; 139: 49-58.